NFE2L2 and Alzheimer disease: Given the widespread effects of Nrf2 and its downstream targets, it is not surprising that CFA, as an Nrf2 activator, leads to parallel alterations in multiple pathways and cellular functions that are essential in AD pathogenesis 64-66 as demonstrated here.